enVVeno Medical Corporation (FRA:5HJ)

Germany · Delayed Price · Currency is EUR

0.334

+0.022 (7.05%)

At close: Dec 4, 2025

-88.24% (1Y)

Market Cap	6.14M
Revenue (ttm)	n/a
Net Income (ttm)	-18.72M
Shares Out	n/a
EPS (ttm)	-0.92
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	250
Open	0.334
Previous Close	0.312
Day's Range	0.334 - 0.334
52-Week Range	0.272 - 4.480
Beta	n/a
RSI	35.88
Earnings Date	Feb 27, 2026

About enVVeno Medical

enVVeno Medical Corporation, a clinical-stage medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease. The company’s lead product is the VenoValve, a replacement venous valve for the treatment of venous chronic venous insufficiency. Its VenoValve implanted into the femoral vein of the patient in an open surgical procedure via a 5-to-6-inch incision in the upper thigh. The company also develops enVVe, a non-surgical and transcatheter-based repla... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 1999

Employees 37

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 5HJ

Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.